206 related articles for article (PubMed ID: 22519449)
1. Matrix metalloproteinases in acute coronary syndromes: current perspectives.
Kampoli AM; Tousoulis D; Papageorgiou N; Antoniades C; Androulakis E; Tsiamis E; Latsios G; Stefanadis C
Curr Top Med Chem; 2012; 12(10):1192-205. PubMed ID: 22519449
[TBL] [Abstract][Full Text] [Related]
2. Matrix Metalloproteinases as Biomarkers of Atherosclerotic Plaque Instability.
Olejarz W; Łacheta D; Kubiak-Tomaszewska G
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486345
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases in cardiovascular disease.
Liu P; Sun M; Sader S
Can J Cardiol; 2006 Feb; 22 Suppl B(Suppl B):25B-30B. PubMed ID: 16498509
[TBL] [Abstract][Full Text] [Related]
4. [Matrix metalloproteinases and atherosclerosis].
Fic P; Zakrocka I; Kurzepa J; Stepulak A
Postepy Hig Med Dosw (Online); 2011 Jan; 65():16-27. PubMed ID: 21357991
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases in pro-atherosclerotic arterial remodeling.
Myasoedova VA; Chistiakov DA; Grechko AV; Orekhov AN
J Mol Cell Cardiol; 2018 Oct; 123():159-167. PubMed ID: 30172754
[TBL] [Abstract][Full Text] [Related]
6. Novel therapeutic approaches targeting matrix metalloproteinases in cardiovascular disease.
Briasoulis A; Tousoulis D; Papageorgiou N; Kampoli AM; Androulakis E; Antoniades C; Tsiamis E; Latsios G; Stefanadis C
Curr Top Med Chem; 2012; 12(10):1214-21. PubMed ID: 22519451
[TBL] [Abstract][Full Text] [Related]
7. Evidence for the Involvement of Matrix-Degrading Metalloproteinases (MMPs) in Atherosclerosis.
Brown BA; Williams H; George SJ
Prog Mol Biol Transl Sci; 2017; 147():197-237. PubMed ID: 28413029
[TBL] [Abstract][Full Text] [Related]
8. Molecular imaging of matrix metalloproteinases in atherosclerotic plaques.
Lenglet S; Thomas A; Chaurand P; Galan K; Mach F; Montecucco F
Thromb Haemost; 2012 Mar; 107(3):409-16. PubMed ID: 22274652
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability.
Johnson JL
Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):265-82. PubMed ID: 17338671
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome.
Jones CB; Sane DC; Herrington DM
Cardiovasc Res; 2003 Oct; 59(4):812-23. PubMed ID: 14553821
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase inhibition with tetracyclines for the treatment of coronary artery disease.
Bench TJ; Jeremias A; Brown DL
Pharmacol Res; 2011 Dec; 64(6):561-6. PubMed ID: 21624471
[TBL] [Abstract][Full Text] [Related]
12. The role of matrix metalloproteinases in atherothrombosis.
Ketelhuth DF; Bäck M
Curr Atheroscler Rep; 2011 Apr; 13(2):162-9. PubMed ID: 21271310
[TBL] [Abstract][Full Text] [Related]
13. Multidimensional Contribution of Matrix Metalloproteinases to Atherosclerotic Plaque Vulnerability: Multiple Mechanisms of Inhibition to Promote Stability.
Ruddy JM; Ikonomidis JS; Jones JA
J Vasc Res; 2016; 53(1-2):1-16. PubMed ID: 27327039
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein induces expression of matrix metalloproteinase-9: a possible link between inflammation and plaque rupture.
Cimmino G; Ragni M; Cirillo P; Petrillo G; Loffredo F; Chiariello M; Gresele P; Falcinelli E; Golino P
Int J Cardiol; 2013 Sep; 168(2):981-6. PubMed ID: 23157807
[TBL] [Abstract][Full Text] [Related]
15. Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability.
Müller A; Krämer SD; Meletta R; Beck K; Selivanova SV; Rancic Z; Kaufmann PA; Vos B; Meding J; Stellfeld T; Heinrich TK; Bauser M; Hütter J; Dinkelborg LM; Schibli R; Ametamey SM
Nucl Med Biol; 2014 Aug; 41(7):562-9. PubMed ID: 24853402
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases and atherosclerosis.
Watanabe N; Ikeda U
Curr Atheroscler Rep; 2004 Mar; 6(2):112-20. PubMed ID: 15023295
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases and coronary artery diseases.
Ikeda U; Shimada K
Clin Cardiol; 2003 Feb; 26(2):55-9. PubMed ID: 12625594
[TBL] [Abstract][Full Text] [Related]
18. Granulocytes in coronary thrombus evolution after myocardial infarction--time-dependent changes in expression of matrix metalloproteinases.
Li X; de Boer OJ; Ploegmaker H; Teeling P; Daemen MJ; de Winter RJ; van der Wal AC
Cardiovasc Pathol; 2016; 25(1):40-6. PubMed ID: 26490693
[TBL] [Abstract][Full Text] [Related]
19. Regulation and involvement of matrix metalloproteinases in vascular diseases.
Amin M; Pushpakumar S; Muradashvili N; Kundu S; Tyagi SC; Sen U
Front Biosci (Landmark Ed); 2016 Jan; 21(1):89-118. PubMed ID: 26709763
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives.
Beaudeux JL; Giral P; Bruckert E; Foglietti MJ; Chapman MJ
Clin Chem Lab Med; 2004 Feb; 42(2):121-31. PubMed ID: 15061349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]